Congenital toxoplasmosis and prenatal care state programs

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Avelino, Mariza M ^a   Amaral, Waldemar N ^a   Rodrigues, Isolina M X ^a   Rassi, Alan R ^a   Gomes, Maria B F ^b   Costa, Tatiane L ^a   Castro, Ana M ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Hospital for Maternal and Child Healthcare   (Brazil)

Author keywords

Congenital toxoplasmosis; Pregnancy; Seronegative

Indexed keywords

COCCIDIOSTATIC AGENT; IMMUNOGLOBULIN A; SPIRAMYCIN; FOLINIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE;

ADULT; BLOOD; BRAZIL; CLINICAL TRIAL; COHORT ANALYSIS; DRUG MONITORING; FEMALE; HUMAN; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVENTION AND CONTROL; PROGNOSIS; PROSPECTIVE STUDY; SEROLOGY; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; VERTICAL TRANSMISSION; ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; FETUS; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL CARE; PARASITE IDENTIFICATION; PUERPERIUM; SEROCONVERSION; SERODIAGNOSIS; TOXOPLASMA GONDII;

ADULT; BRAZIL; COCCIDIOSTATS; COHORT STUDIES; DRUG MONITORING; FEMALE; HUMANS; IMMUNOGLOBULIN A; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROGNOSIS; PROSPECTIVE STUDIES; SEROLOGIC TESTS; SPIRAMYCIN; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 84892450299     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-33     Document Type: Article

References (98)

1. Eichenwald HF. A study of congenital toxoplasmosis with a particular emphasis on clinical manifestations, sequelae and therapy. Human toxoplasmosis.Volume 2 1959, 41-49. Copenhagen: Munksgaard, Siim JC.
2. Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. New Engl J Med 1974, 290(20):1110-1116. 10.1056/NEJM197405162902003, 4821174.
3. Koppe JG, Loewer SDH, Roever BH. Results of 20 years follow-up congenital toxoplasmosis. Lancet 1986, 1:254-256.
4. Petrof E. McLeod R. Toxoplasma gondii and Toxoplasmosis. Therapy of infectious diseases 2002, 653-696. Philadelphia: WB Saunders, Badour L, Gorbach S.
5. Remington JS, Mc Leod R, Wilson CB, Desmonts G. Toxoplasmosis. Infectious diseases of the fetus and newborn infant 2011, 915-1041. Pennsylvania: Elsevier Saunders, Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA, 7.
6. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial. Clin Infect Dis 1994, 18:38-72. 10.1093/clinids/18.1.38, 8054436.
7. McAuley JB, Boyer K, Remington JS, McLeod R. Toxoplasmosis. Textbook of pediatric infectious diseases, volume 235 2009, 2954-2971. United States of America: Saunders Elsevier, 6.
8. Phan L, Kasza K, Jalbrzikowski J, Noble AG, Latkany P, Kuo A, Mieler W, Meyers S, Rabiah P, Boyer K, Swisher C, Mets M, Roizen N, Cezar S, Sautter M, Remington J, Meier P, McLeod R. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol 2008, 146:375-384. 10.1016/j.ajo.2008.04.033, 2747816, 18619570.
9. Brézin AP, Thulliez P, Couvreur J, Nobré R, Mcleod R, Mets MB. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 2003, 135:779-784. 10.1016/S0002-9394(02)01704-X, 12788116.
10. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980, 66:767-774.
11. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, Jenum PA, Hedman K, Naessens A. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at one year of age. Am J Obstet Gynecol 1999, 180:410-415. 10.1016/S0002-9378(99)70224-3, 9988811.
12. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, Jalbrzikowski J, Remington J, Heydemann P, Noble AG, Mets M, Holfels E, Withers S, Latkany P, Meier P. Outcome of treatment for congenital toxoplasmosis, 1981-2004: The national collaborative Chicago-based, congenital toxoplasmosis study. Clin Infect Dis 2006, 42:1383-1394. 10.1086/501360, 16619149.
13. Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis 2011, 30:597-600.
14. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001, 30:1303-1308. 10.1093/ije/30.6.1303, 11821334.
15. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis 2008, 2:277.
16. Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Inter J Epidemiol 2001, 30:1309-1313.
17. Lopes-Mori RFM, Mitsuka-Breganó R, Capobiango JD, Teruo Inoue I, Reiche EMV, Morimoto HK, Casella AMB, Bittencourt LHFB, Freire RL, Navarro IT. Programs for control of congenital toxoplasmosis. Brazil Rev Med Ass 2011, 57(5):581-586. http://dx.doi.org/101590/S0104-43-2302001100500021.
18. Avelino MM, Campos D, Parada JB, Castro AM. Risk factors for Toxoplasma gondii infection in women of childbearing age. BJID 2004, 8(2):164-174.
19. Avelino MM, Campos D, Barbosa JCB, Castro AM. Pregnancy as a risk factor to acute toxoplasmosis seroconvertion. Eur J Obstet Gynecol Reprod Biol 2003, 108:19-24. 10.1016/S0301-2115(02)00353-6, 12694964.
20. Daunter M. Immunology of pregnancy: towards aunifynd hypotesys. Eur J Obstet Gynecol Reprod Biol 1992, 43:81-95. 10.1016/0028-2243(92)90064-6, 1563565.
21. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child 2006, 91(8):661-665. 10.1136/adc.2004.066514, 2083029, 16861484.
22. Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012, 139(11):1375-1424. 10.1017/S0031182012000765, 22776427.
23. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy an epidemiologic survey over 22 consecutive years. J Perinat Med 2004, 32(3):211-214.
24. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 2011, 30(12):1056-1061. 10.1097/INF.0b013e3182343096, 21956696.
25. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?. J Med Screen 2002, 9:135-141. 10.1136/jms.9.3.135, 12370327.
26. Flatt A, Shetty N. Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse population. Eur Public Health 2013, 23(4):648-652.
27. Gilbert R, Gras L. European Multicentre Study on congenital toxoplasmosis effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003, 110:112-120.
28. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy. Rev Cochrane Library 1999, Issue 3, Art No. CD001684.DOI 10.1002/14651858.CD001684.
29. Thiébaut R, Leproust S, Chêne G, Gilbert R. SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients data. Handb Clin Neurol 2013, 112:1099-101. DOI:10.1016/B978-0-444-52910-7.00028-3.
30. Kieffer F, Wallon M. Congenital toxoplasmosis. Handb Clin Nuerol 2013, 112:1099-1101. doi:10.1016/B978-0-444-52910-7.00028-3.
31. Stillwaggon E, Carrier CS, Sautter M, McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011, 5(9):1333. PMC3181241.
32. Geneviève C, Rodolphe T. Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Mem Inst Oswaldo Cruz 2009, 104(2):299-304. http://dx.doi.org/101590/S0074-02762009000200025, 10.1590/S0074-02762009000200025, 19430657.
33. Foulon W, Naessens A, Lauwers S, De Meuter F, Amy JJ. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 1988, 72:363-366.
34. Douche C, Benabdesselam A, Mokhtari F, Le Mer Y. Value of prevention of congenital toxoplasmosis. J Fr Ophtalmol 1996, 19:330-334.
35. Roux C, Desmonts G, Mulliez N, Gaulier M, Tufferaud G, Marmor D, Herbillon A. Toxoplasmosis and pregnancy. Evaluation of 2 years of prevention of congenital toxoplasmosis in the maternity ward of Hôpital Saint-Antoine (1973-1974). J Gynecol Obstet Biol Reprod 1976, 5:249-264.
36. Ricci M, Pentimalli H, Thaller R, ravà L, Di Ciommo V. Screening and prevention of congenital toxoplasmosis: An effectiveness study in a population with a high infection rate. J Mat Fetal Neonatal Med 2003, 14:398-403.
37. Di Mario S, Basevi V, Gagliotti C, Spettoli D, Gori G, D'Amico R, Magrini N. Prenatal education for congenital toxoplasmosis 2009, Cochrane Pregnancy and Childbirth Group, Cochrane Database Syst Rew 2013, Issue 2, Art No. 3 CD006171.DOI.1002/14651858.CD006171 pub.
38. Gilbert R. Treatment for congenital toxoplasmosis: finding out what works. Mem Inst Oswaldo Cruz 2009, 104(2). http://dx.doi.org/101590/S0074-02762009000200026.
39. Wallon M, Liou C, Garner P, François F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999, 318:1511. 10.1136/bmj.318.7197.1511, 27891, 10356003.
40. Eskild A, Magnus P. Little evidence of effective prenatal treatment against congenital toxoplasmosis-the implications for testing in pregnancy. Int J Epidemiol 2001, 30:1314-1315. 10.1093/ije/30.6.1314, 11821336.
41. Boyer KM, Holfels E, Roizen N, Swisher C, Mack D, Remington JS, Withers S, Meier P, McLeod R. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening. Am J Obstet Gynecol 2005, 192:564-571. 10.1016/j.ajog.2004.07.031, 15696004.
42. Montoya JG, Remington JS. Management of Toxoplasma gondii Infection during Pregnancy. Clin Infect Dis 2008, 47:554-566. 10.1086/590149, 18624630.
43. Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis 1992, 84(Suppl):43-45.
44. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992, 84(Suppl):32-77.
45. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Bonithon C, Kopp C, Binquet C. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 2013, 56(9):1223-1231. 10.1093/cid/cit032, 23362291.
46. Logar J, Petrovec M, Novak-Antolic Z, Premru-Srsen T, Cizman M, Arnez M, Kraut A. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant woman. Scand J Infect Dis 2002, 34:201-204. 10.1080/00365540110080386, 12030394.
47. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, Mac Alisee J, Descombey D. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989, 115:765-769. 10.1016/S0022-3476(89)80660-2, 2681638.
48. Forestier F. Les foetopathies infectieuses: prevention, diagnostic prenatal, attitude pratique. Presse Med 1991, 20:1448-1454.
49. Binquet C, Wallon M, Quantin C, Kodjikian L, Garweg J, Fleury J, Peyron F, Abrahamow M. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 2003, 131:1157-1168. 10.1017/S0950268803001316, 2870066, 14959784.
50. Hotop A, Hlobil H, Groß U. Efficacy of rapid treatment initiation following primary toxoplasma gondii infection during pregnancy. Clin Infect Dis 2012, 54(11):1545-1552. 10.1093/cid/cis234, 22460980.
51. Cortina Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE, et al. European Multicenter Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PloS Med 2010, 7(10). doi:10.1371/journal.pmed1000351.
52. Meroni V, Genco F. Screening for toxoplasmosis during pregnancy: one-year experience in an Italian reference laboratory. Scientia Med 2010, 20(1):35-39.
53. Nowakowska D, Stray-Pedersen B, Spiewark E, Sobala W, Matafiej E, Wilczynski J. Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin Microbiol Infect 2006, 12:913-917. 10.1111/j.1469-0691.2006.01513.x, 16882298.
54. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, Petersen E, Gilbert R. European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005, 94(12):1721-1731. 10.1080/08035250500251999, 16421031.
55. Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, Teramo K, Koskela P. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 1995, 27:265-272. 10.3109/00365549509019020, 8539552.
56. Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, Paquet C, Yudin MH, Allen VM, Bouchard C, Boucher M, Caddy S, Castillo E, Money DM, Murphy KE, Ogilvie G, van Schalkwyk J. Toxoplasmosis in pregnancy:prevention, screening, and treatment. J Obstet Gynaecol Can 2013, 35(1e Suppl A)):S1-S7.
57. Galanakis E, Manoura A, Antoniou M, Sifakis S, Korakaki E, Hatzidaki E, Lambraki D, Tselentis Y, Giannakopoulou C. Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy. Fetal Diagn Ther 2007, 22:444-448. doi:10.1159/000106352, 10.1159/000106352, 17652934.
58. Moncada PA, Montoya JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther 2012, 10(7):815-828. doi:10.1586/eri.12,58, 10.1586/eri.12.58, 22943404.
59. Thulliez P. Commentary: efficacy of prenatal treatment for toxoplasmosis: a possibility that cannot be ruled out. Int J Epidemiol 2001, 30:1315-1316. 10.1093/ije/30.6.1315, 11821337.
60. Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita 2004, 40(1):81-8.
61. Jenun PA, Stray PB, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997, 35(8):1972-1977. 229886, 9230365.
62. Werblin TO, Kim YT, Quagliata F, Siskind GW. Studies on the control of antibody synthesis. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology 1973, 24:477-492. 1422981, 4574576.
63. Minuzzi ALM. [Port]. Análise comparativa entre testes ELISA convencional (soro) e papel filtro (sangue seco) para detecção de IgM anti. Toxoplasma. Comparative analysis between conventional ELISA (serum) and filter paper (dried blood) for detection of IgM anti-Toxoplasma 2008, 60. Brasilia, Brazil: Master's thesis, Faculty of Health Sciences, University of Brasilia.
64. Figueiró-Filho EA, Lopes AHA, Selefonte FRA, Souza Júnior VG, Carlos Augusto Botelho CA, Figueiredo MS, Duarte G. Toxoplasmose aguda: estudo da frequência, taxa de transmissão vertical e relação entre os testes diagnósticos materno fetais em gestantes em estudo da Região Centro Oeste do Brasil. Rev Bras Ginecol Obstet 2005, 27(8):442-449.
65. Silva MG, Junior RSL, Costa TL, Soares JDH, Amaral WN, Avelino MM, Castro AM. Anatomophathological study in BALB/c mice brains experimentally infected with Toxoplasma gondii. BJID 2008, 12(1):47-51.
66. Santos FR, Pena SDJ, Epplen JT. Genetic and population study of a y-linked tetranucleotide repect DNA polymorphism with a simple non-isotopic technique. Hum Genetics 1993, 90:655-656.
67. Camargo ME, Leser PG. Diagnostic information from serological tests in human toxoplasmosis. II Evolutive study of antibodies and serological patterns in acquired toxoplasmosis, as detected by hemagglutination, complement fixation, IgG and IgM-immunofluorescence tests. Rev Inst Med Trop Sao Paulo 1976, 18(4):227-238. doi:4.
68. Camargo ME. Improved technique of indirect immunofluorescence for serological diagnosis of toxoplasmosis. Rev Inst Med Trop S Paulo 1964, 6:117-118.
69. Rodrigues IMX, Castro AM, Gomes MBF, Amaral WN, Avelino MM. Congenital toxoplasmosis: evaluation of serologic. Mem Inst Oswaldo Cruz 2009, 104(3):434-440. 10.1590/S0074-02762009000300006, 19547868.
70. Couvreur J, Desmonts G, Thulliez P. Prophylaxis of congenital toxoplasmosis: effects of spiramycin on placental infection. J Antimicrob Chemother 1988, 22:193-200.
71. Couvreur J, Thulliez P, Daffos F, Aufrant C, Bompard Y, Gesquiére A, Desmonts G. Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides. Arch Fr Pediatr 1991, 48(6):397-403.
72. Avelino MM, Parada JCB, Castro AM, Alves MFC, Campos D. Toxoplasma gondii primary infection in pregnant women in Goiânia: a seroconversion study. J Med Biol Sci 2009, 8(3):325-333.
73. Sagel U, Krämer A. Screening of Maternal Toxoplasmosis in Pregnancy: Laboratory Diagnostics from the Perspective of Public Health Requirements. J Bacteriol Parasitol 2013, S:5.
74. Montoya JG. Laboratory Diagnosis of Toxoplasma gondii Infection and Toxoplasmosis. J Infect Dis 2002, 185(Suppl 1):S73-S82. doi:10.1086/338827.
75. Bessieres MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 2009, 104(2):358-363. http://dx.doi.org/10.1590/S0074-02762009000200038, 10.1590/S0074-02762009000200032, 19430664.
76. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E. [The European Multicentre Study on Congenital Toxoplasmosis- EMSCOT]. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 2007, 14(1):8-13. 10.1258/096914107780154440, 17362565.
77. Pinon JM, Dumon H, Chemla C, Franck J, Petersen P, Lebech M, Zufferey J, Bessieres HM, Marty P, Holliman R, Johnson J, Luyasu V, Lecolier B, Guy E, Joynson DHM, Decoster A, Enders G, Pelloux H, Candolfi E. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001, 39(6):2267-2271. doi:10.1128/JCM.39.6.2267-2271.2001, 10.1128/JCM.39.6.2267-2271.2001, 88122, 11376068.
78. Carvalheiro CG, Mussi-Pinhata MM, Yamamoto AY, De Souza CB, Maciel LM. Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiol Infect 2005, 133(3):485-491. 10.1017/S095026880400353X, 2870272, 15962555.
79. Bessières MH, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, Courjault C, Séguéla JP. Neonatal screening for CT in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biology 2001, 94:37-45.
80. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, Villena I, Jenum PA, Hayde M, Naessens A. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999, 181(4):843-847. 10.1016/S0002-9378(99)70311-X, 10521739.
81. Knerer B, Hayde M, Gratz G, Bernaschek G, Strobl W, Pollak A. Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection. Wien Klin Wochenschr 1995, 107:137-140.
82. Vidigal PVT, Santos DVV, Castro FC, Couto JCF, Vitor RWA, Brasileiro FG. Prenatal toxoplasmosis diagnosis from amniotic fluid by PCR. Rev Soc Bras Med Trop 2002, 35:1-6.
83. Thalib L, Gras L, Romand S, Prusa A, Bessieres MH, Petersen E, Gilbert RE. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG 2005, 112(5):567-574. 10.1111/j.1471-0528.2005.00486.x, 15842278.
84. Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 1990, 28:2297-2301. 268165, 2229355.
85. Alford CA, Stagno S, Reynalds DW. Congenital toxoplasmosis: clinical, laboratory and therapeutic considerations with special reference to subclinical disease. Bull NY Acad 1974, 50(2):160-181.
86. Wallon M, Caudie C, Rubio S, Bellini L, Girault V, Gay-Andrieu F, Peyron F. Value of cerebrospinal fluid cytochemical examination for the diagnosis of congenital toxoplasmosis at birth in France. Pediatr Infect Dis J 1998, 17(8):705-710. 10.1097/00006454-199808000-00009, 9726345.
87. Desmonts G, Couvreur J, Thulliez P. Toxoplasmose conge'nitale: cinq cas de transmission a′ l'enfant d'une infection maternelle ante'rieure à' la grossesse. Presse Med 1990, 19:1445-1449.
88. Andrade GM, Vasconcelos-Santos DV, Carellos EV, Romanelli RM, Vitor RW, Carneiro AC, Januario JN. Congenital toxoplasmosis from a chronically infected woman with reactivation of retinochoroiditis during pregnancy. J Pediatr 2010, 86(1):85-88. doi:10.2223/JPED.1948. Epub 2009 Nov 16.
89. Elbez-Rubinstein A, Ajzenberg D, Dardé M-L, Cohen R, Dumètre A, Yera H, Gondon H, Janaud J-C, Thulliez P. Congenital Toxoplasmosis and Reinfection during pregnancy: Case report, strain characterization, experimental model of reinfection, and review. J Infect Dis 2009, 199:280-285. doi:10.1086/595793, 10.1086/595793, 19032062.
90. Valdès V, Legagner H, Watrin V, Paris L, Hascoet JM. Congenital toxoplasmosis due to maternal reinfection during pregnancy. Arch Pediatr 2011, 18(7):761-763. 10.1016/j.arcped.2011.04.011, 21600743.
91. Gollub EL, Leroy V, Gilbert R, Chene G, Wallon M. Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol 2008, 136:137-145. 10.1016/j.ejogrb.2007.09.010, 17977641.
92. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health 2008, 122(4):335-353. 10.1016/j.puhe.2007.08.009, 17964621.
93. Safádi MA, Berezin EN, Farhat CK, Carvalho ES. Clinical presentation and follow up of children with congenital toxoplasmosis in Brazil. Braz J Infect Dis 2003, 7(5):325-331.
94. Soares JA, Carvalho SF, Caldeira AP. Profile of pregnant women and children treated at a reference center for congenital toxoplasmosis in the northern state of Minas Gerais, Brazil. Rev Soc Bras Med Trop 2012, 45(1):55-59. 10.1590/S0037-86822012000100011, 22370829.
95. Melamed J. Contributions to the history of ocular toxoplasmosis in Southern Brazil. Mem Inst Oswaldo Cruz 2009, 104(2):383-388. http://dx.doi.org/10.1590/S0074-0276200900020003, 10.1590/S0074-02762009000200037, 19430669.
96. Kieffer F, Rigourd V, Ikounga P, Bessieres B, Magny JF, Thulliez P. Disseminated congenital toxoplasma infection with a type II strain. Pediatr Infect Dis J 2011, 30(9):813-815. doi:10.1097/INF.0b013e31821b8dfe, 10.1097/INF.0b013e31821b8dfe, 21494173.
97. Cneude F, Deliège R, Barbier C, Durand-Joly I, Bourlet A, Sonna M, El Kohen R, Locquet A, Vittu G, Decoster A. Septic shock due to congenital disseminated toxoplasmosis?. Arch Pediatr 2003, 10(4):326-328. 10.1016/S0929-693X(03)00034-4, 12818753.
98. Salviz M, Montoya JG, Nadol JB, Santos F. Otopathology in congenital toxoplasmosis. Otol Neurotol 2013, 34(6):1165-1169. doi:10.1097/MAO.0b013e31828297b6, 10.1097/MAO.0b013e31828297b6, 23598697.